Current Computer - Aided Drug Design

780 papers and 8.7k indexed citations i.

About

The 780 papers published in Current Computer - Aided Drug Design in the last decades have received a total of 8.7k indexed citations. Papers published in Current Computer - Aided Drug Design usually cover Computational Theory and Mathematics (404 papers), Molecular Biology (313 papers) and Organic Chemistry (239 papers) specifically the topics of Computational Drug Discovery Methods (404 papers), Synthesis and biological activity (158 papers) and Click Chemistry and Applications (49 papers). The most active scholars publishing in Current Computer - Aided Drug Design are Hong‐Xing Zhang, Xuan-Yu Meng, Mihaly Mezei, Meng Cui, Tingjun Hou, Xiaojie Xu, Junmei Wang, Hong‐Yu Zhang, Subhash C. Basak and Mark T.D. Cronin.

In The Last Decade

Fields of papers published in Current Computer - Aided Drug Design

Since Specialization
EngineeringComputer SciencePhysics and AstronomyMathematicsEarth and Planetary SciencesEnergyEnvironmental ScienceMaterials ScienceChemical EngineeringChemistryAgricultural and Biological SciencesVeterinaryDecision SciencesArts and HumanitiesBusiness, Management and AccountingSocial SciencesPsychologyEconomics, Econometrics and FinanceHealth ProfessionsDentistryMedicineBiochemistry, Genetics and Molecular BiologyNeuroscienceNursingImmunology and MicrobiologyPharmacology, Toxicology and Pharmaceutics

This network shows the specialization of papers published in Current Computer - Aided Drug Design. Nodes represent fields, and links connect fields that are likely to share authors.

Countries where authors publish in Current Computer - Aided Drug Design

Since Specialization
Total citations of papers

This map shows the geographic distribution of research published in Current Computer - Aided Drug Design. It shows the number of citations received by papers published by authors working in each country. You can also color the map by specialization and compare the number of papers published in Current Computer - Aided Drug Design with the expected number of papers based on a country's size and research output (numbers larger than one mean the country's share of papers is larger than expected).

Rankless by CCL
2025